Insights & Publications
© 2018 Debevoise & Plimpton LLP
New Public and Private Efforts to Contain Healthcare Costs: What it Means for the Healthcare Industry
20 December 2017
View Client Update
As healthcare costs continue to climb, both public and private payors are pursuing strategies to expand access and contain costs.
The FDA and state governments have recently announced initiatives that are aimed at directly or indirectly reducing prescription drug costs.
Healthcare companies are using vertical integration as a means of controlling costs and developing new means of providing reasonably-priced, accessible healthcare.
These initiatives provide strategic opportunities for healthcare companies that can enhance the efficacy and cost-effectiveness of healthcare goods and services.
Mergers & Acquisitions
Andrew L. Bab
Jennifer L. Chu
Mark P. Goodman
Maura Kathleen Monaghan
View More Authors
EU Anti-Money Laundering Developments: Fifth Directive Published and Sixth Directive Imminent
Debevoise Prevails in Precedent-Setting Tax Case at North Carolina Supreme Court
Debevoise Partner Paul D. Rubin among Panelists at ACI’s 6th Annual Legal, Regulatory and Compliance Forum on Dietary Supplements
Debevoise Partner Jennifer L. Chu Speaks at PLI Seminar on Acquiring and Selling Privately Held Companies
UK Modern Slavery Act Transparency Statement
Debevoise Women's Review